Greg Behar, Recipharm CEO
April 12, 2024 01:43 PM EDTUpdated 02:22 PM
Manufacturing

Re­ci­pharm’s new CEO on ‘fast and fu­ri­ous’ changes, with eyes on GLP-1, bi­o­log­ics man­u­fac­tur­ing

Anna Brown

News Reporter

Just over three months in­to his new role as the CEO of Re­ci­pharm, Greg Be­har is al­ready mak­ing siz­able changes to the CD­MO’s en­gine. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

Will CRISPR mat­ter?

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times